(Q40098112)

17 September 2017

title

The role of dopaminergic depletion in the pathogenesis of Cushing's disease and the possible consequences for medical therapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A198166

29 December 2022

1 reference

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1977.TB01314.X

29 December 2022

author name string

S. W. Lamberts

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A198166

29 December 2022

H. A. Timmermans

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A198166

29 December 2022

F. H. De Jong

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A198166

29 December 2022

J. C. Birkenhager

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A198166

29 December 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=198166

29 December 2022

publication date

1 September 1977

1 reference

full work available at URL

17 September 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1365-2265.1977.tb01314.x

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1977.TB01314.X

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2265.1977.tb01314.x/fullpdf

29 December 2022

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1977.TB01314.X

29 December 2022

published in

Clinical Endocrinology

1 reference

17 September 2017

volume

7

1 reference

17 September 2017

issue

3

1 reference

17 September 2017

page(s)

185-193

1 reference

Indirect analysis of corticosteroids. I. The determination of 17-hydroxycorticosteroids

17 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.1977.TB01314.X

Effect of ergot drugs on central catecholamine neurons: evidence for a stimulation of central dopamine neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.1977.TB01314.X

Growth hormone and cortisol responsiveness in Cushing's syndrome. Relation to a possible central nervous system etiology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.1977.TB01314.X

Hydrocortisone-production rates in Africans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.1977.TB01314.X

Effects of growth hormone release-inhibiting hormone and bromocryptine (CB 154) in states of abnormal pituitary-adrenal function

21 January 2018

2

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1977.TB01314.X

Changes in Plasma Growth Hormone Levels in Normal and Acromegalic Subjects Following Administration of 2-Bromo-α-Ergocryptine

29 December 2022

4

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1977.TB01314.X

Effects of Glucocorticoids on Pituitary Hormonal Responses to Hypoglycemia. Inhibition of Prolactin Release*

29 December 2022

5

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1977.TB01314.X

HUMAN GROWTH HORMONE. CLINICAL MEASUREMENT, RESPONSE TO HYPOGLYCEMIA AND SUPPRESSION BY CORTICOSTEROIDS

29 December 2022

7

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1977.TB01314.X

Prolactin Synthesis and Secretion in a Patient with the Forbes Albright Syndrome

29 December 2022

8

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1977.TB01314.X

EFFECT OF CORTICOSTEROIDS ON SERUM GROWTH HORMONE

29 December 2022

9

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1977.TB01314.X

A fundamental defect of adrenocortical control in Cushing's disease.

29 December 2022

10

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1977.TB01314.X

Determination of dehydroepiandrosterone and dehydroepiandrosterone sulphate in human plasma using electron capture detection of 4-androstene-3,6,17-trione after gas-liquid chromatography

29 December 2022

11

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1977.TB01314.X

Absence of nocturnal elevation of plasma prolactin concentrations in Cushing's disease

29 December 2022

13

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1977.TB01314.X

Thyrotrophin and prolactin responsiveness to thyrotrophin releasing hormone in Cushing's disease

29 December 2022

14

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1977.TB01314.X

Effect of bromocriptine in pituitary-dependent Cushing's syndrome

29 December 2022

16

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1977.TB01314.X

Human Prolactin and Growth Hormone Release during Surgery and other Conditions of Stress1

29 December 2022

18

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1977.TB01314.X

Influence of Glucocorticoids on TRF-Induced TSH Response in Man

29 December 2022

20

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1977.TB01314.X

The effect of glucocorticoid administration on human pituitary secretion of thyrotropin and prolactin.

29 December 2022

21

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1977.TB01314.X

29 December 2022

Identifiers

1 reference

17 September 2017

1 reference